.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Fuji
Federal Trade Commission
UBS
Healthtrust
Moodys
Novartis
Teva
McKesson
US Department of Justice

Generated: June 26, 2017

DrugPatentWatch Database Preview

ISOVUE-M 200 Drug Profile

« Back to Dashboard

Which patents cover Isovue-m 200, and what generic Isovue-m 200 alternatives are available?

Isovue-m 200 is a drug marketed by Bracco and is included in one NDA.

The generic ingredient in ISOVUE-M 200 is iopamidol. There are eleven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the iopamidol profile page.

Summary for Tradename: ISOVUE-M 200

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list25
Clinical Trials: see list3,470
Patent Applications: see list1,590
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ISOVUE-M 200 at DailyMed

Pharmacology for Tradename: ISOVUE-M 200

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco
ISOVUE-M 200
iopamidol
INJECTABLE;INJECTION018735-001Dec 31, 1985RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ISOVUE-M 200

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bracco
ISOVUE-M 200
iopamidol
INJECTABLE;INJECTION018735-001Dec 31, 19854,001,323► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Deloitte
Medtronic
US Department of Justice
Express Scripts
Baxter
Fuji
Cantor Fitzgerald
Federal Trade Commission
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot